Oscar Health Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Oscar Health stock has a consensus rating of "Hold" and an average price target of $21.2. The average 1-year stock price forecast is 13.50% lower than the current stock price, while the lowest is $11 (-55.12%) and the highest is $30 (+22.40%).

Price Target: $21.2 (-13.50%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$11	$21.2	$21	$30
Change	-55.12%	-13.50%	-14.32%	+22.40%

Analyst Ratings

The average analyst rating for Oscar Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	0	0	0	0	0	0
Buy	1	1	2	2	2	2
Hold	4	6	5	5	6	7
Sell	2	1	1	1	1	1
Strong Sell	3	2	2	2	1	1
Total	10	10	10	10	10	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew Mok CFA Barclays	Barclays	Hold Maintains $21 → $30	Hold	Maintains	$21 → $30	+22.40%	May 26, 2026
Scott Fidel Goldman Sachs	Goldman Sachs	Hold Reiterates $17 → $22	Hold	Reiterates	$17 → $22	-10.24%	May 11, 2026
Michael Ha Robert W. Baird	Robert W. Baird	Hold Maintains $15 → $19	Hold	Maintains	$15 → $19	-22.48%	May 7, 2026
Michael Craig Jones Bank of America Securities	Bank of America Securities	Sell Maintains $11 → $13	Sell	Maintains	$11 → $13	-46.96%	May 7, 2026
Jonathan Yong UBS	UBS	Hold Maintains $15 → $20	Hold	Maintains	$15 → $20	-18.40%	May 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

18.58B

from 11.70B

58.75%

from 11.70B

Revenue Next Year

19.85B

from 18.58B

6.84%

from 18.58B

EPS This Year

1.07

from -1.69

EPS Next Year

1.46

from 1.07

36.18%

from 1.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.89B	3.96B	5.86B	9.18B	11.70B	18.58B
Revenue Growth	384.43%	109.27%	47.92%	56.54%	27.50%	58.75%
Net Income	-572.61M	-606.28M	-270.73M	25.43M	-443.15M	383.51M
EPS	-	-	-	-	-1.69	1.07
Forward PE	-	-	-	28.43	-	22.85
Free Cash Flow	-253.85M	-230.88M	538.86M	1.04B	698.00M	3.38B
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	18.9B
Avg	18.6B
Low	17.2B

Revenue Growth

Revenue Growth	2026	2027	2028
High	61.8%
Avg	58.8%
Low	46.6%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	1.07
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-